Ms Vairavan is the vice president, finance and investor relations, where she is responsible for all investor relations activities as well as overseeing financial planning and consolidation of revenue, gross-to-net, and expenses for all functions. She joined the company as executive director, financial planning and analysis in 2020. Previously, Ms Vairavan was at Amgen for over 15 years, where she held various roles of increasing responsibility within the finance organization, culminating as finance director for US value and access, where she modeled the impact of reimbursement policy changes and liaised with state government affairs teams on various state related drug pricing requirements. Ms Vairavan started her career as a financial consultant working for KPMG and Arthur Andersen. She holds a BS in Business Administration, Finance, from the University of Southern California, and is a licensed CPA in California.